Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
IBD
Characterization of Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in IBD
2 other identifiers
observational
40
1 country
1
Brief Summary
The purpose of this study is to examine the effects of different environmental factors on immune cells in patients with IBD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 3, 2009
CompletedFirst Posted
Study publicly available on registry
June 5, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedJune 5, 2009
June 1, 2009
7 years
June 3, 2009
June 4, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Migration towards chemokines,proliferation, cytokine secretion, phenotypical characterization.
Once, when joining the study
Study Arms (2)
IBD patients
Approximately 40 patients (adults and children) suffering from IBD will be enrolled.
Controls
Approximately 100 healthy controls
Eligibility Criteria
Adults and children aged 10-80. Research group: Approximately 40 patients (adults and children) suffering from IBD will be enrolled. Control group: Approximately 100 controls will be enrolled in the research.
You may qualify if:
- IBD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dep. of Gastroenterology, Tel Aviv medical center
Tel Aviv, Israel
Biospecimen
15 ml peripheral blood will be obtained from all participants.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iris Dotan, MD
Tel-Aviv Sourasky Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
June 3, 2009
First Posted
June 5, 2009
Study Start
July 1, 2007
Primary Completion
July 1, 2014
Last Updated
June 5, 2009
Record last verified: 2009-06